[Renal cell carcinoma management and therapies in 2010]. [electronic resource]
Producer: 20100519Description: 17-28 p. digitalISSN:- 1769-6917
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Bevacizumab
- Carcinoma, Renal Cell -- drug therapy
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Everolimus
- Humans
- Indoles -- therapeutic use
- Interferons -- therapeutic use
- Interleukin-2 -- therapeutic use
- Intracellular Signaling Peptides and Proteins -- antagonists & inhibitors
- Kidney Neoplasms -- drug therapy
- Metabolic Networks and Pathways -- drug effects
- Nephrectomy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Pyridines -- therapeutic use
- Pyrroles -- therapeutic use
- Sirolimus -- analogs & derivatives
- Sorafenib
- Sunitinib
- TOR Serine-Threonine Kinases
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.